IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Colon Cancer Stage III
IFOM ETS - The AIRC Institute of Molecular Oncologymonoclonal_antibodyPhase 3Active
BB
69/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 56/ 100
- Competitive Position
- 95/ 100
Competitive context
157 Active assets in the Colon Cancer Stage III cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FLUOROURACILUM Akeso | Phase 4 | A |
Irinotecan Fudan University | Phase 3 | BBB |
Floxuridine City of Hope Medical Center | Phase 2 | BBB |
FLUOROURACILUM Akeso | Phase 4 | BB |
Eloxatin Sun Yat-sen University | Phase 3 | BB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →